Type a term, then click a field below.

Search | advanced search

keepers


Type a term, then click a field below.

Search | simple search





1 subtopic

 

  • Cisplatin

Platinum CompoundsFollow by RSS 

You've reached a pubget topic page. Below are the latest papers on this topic, with subtopics on the left.

keywords > Inorganic Chemicals > Platinum Compounds

Latest papers

Peroxidase activity of DNA aptamer-pt complexes prepared with cisplatin.

Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer.

Patterns of relapse after chemotherapy in patients with high-risk non-seminomatous germ cell tumor.

Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting.

Pharmacogenomics of Taxane/Platinum Therapy in Ovarian Cancer

Changing the Paradigm in the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer

Symptom Control in Patients With Recurrent Ovarian Cancer

Increased sensitivity to platinating agents and arsenite in human ovarian cancer by downregulation of ASNA1

[Safety of PLD in the treatment of the patients with recurrent ovarian cancer--clinical experience].

In vitro and in vivo optimization of an anti-glioma modality based on synchrotron X-ray photoactivation of platinated drugs.

A tale of two corneal tattoos.

Synthesis and biological evaluation of platinum–acridine hybrid agents modified with bipyridine non-leaving groups

Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(II) anticancer complexes.

Recent Achievements and Future Developments in Advanced and Recurrent Cervical Cancer: Trials of the Gynecologic Oncology Group

The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds.

Management of Recurrent Ovarian Carcinoma: Current Status and Future Directions

Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy.

Epidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy.

Bevacizumab in non-small cell lung cancer: new indication. Too many adverse effects to justify its use.

A bioaccumulative cyclometalated platinum(II) complex with two-photon-induced emission for live cell imaging.

page 1 2 3 4 5 6 7 8 9 10 11 ...